Kumar S - Search Results

1

Mechanisms and prospects of piezoelectric materials as smart delivery vehicles in cancer treatment.

Fayaz H, Gupta T, Rab SO, Jha SK, Kumar S. Fayaz H, et al. Among authors: kumar s. Drug Discov Today. 2024 Feb;29(2):103862. doi: 10.1016/j.drudis.2023.103862. Epub 2023 Dec 18. Drug Discov Today. 2024. PMID: 38122966 Review.

2

A Comprehensive Review on Hydrogels.

Chopra H, Singh I, Kumar S, Bhattacharya T, Rahman MH, Akter R, Kabir MT. Chopra H, et al. Among authors: kumar s. Curr Drug Deliv. 2022;19(6):658-675. doi: 10.2174/1567201818666210601155558. Curr Drug Deliv. 2022. PMID: 34077344 Review.

3

Wound dressings: Recent updates.

Chopra H, Kumar S, Safi SZ, Singh I, Emran TB. Chopra H, et al. Among authors: kumar s. Int J Surg. 2022 Aug;104:106793. doi: 10.1016/j.ijsu.2022.106793. Epub 2022 Jul 31. Int J Surg. 2022. PMID: 35918007 Free article. No abstract available.

4

In Vitro and In Silico Characterization of Curcumin-Loaded Chitosan-PVA Hydrogels: Antimicrobial and Potential Wound Healing Activity.

Chopra H, Bibi S, Mohanta YK, Kumar Mohanta T, Kumar S, Singh I, Saad Khan M, Ranjan Rauta P, Alshammari A, Alharbi M, F Alasmari A. Chopra H, et al. Among authors: kumar mohanta t, kumar s. Gels. 2023 May 9;9(5):394. doi: 10.3390/gels9050394. Gels. 2023. PMID: 37232986 Free PMC article.

5

Biopolymer-based Scaffolds for Tissue Engineering Applications.

Chopra H, Kumar S, Singh I. Chopra H, et al. Among authors: kumar s. Curr Drug Targets. 2021;22(3):282-295. doi: 10.2174/1389450121999201102140408. Curr Drug Targets. 2021. PMID: 33143611 Review.

6

Strategies and Therapies for Wound Healing: A Review.

Chopra H, Kumar S, Singh I. Chopra H, et al. Among authors: kumar s. Curr Drug Targets. 2022;23(1):87-98. doi: 10.2174/1389450122666210415101218. Curr Drug Targets. 2022. PMID: 33858310 Review.

7

Meloxicam carbopol-based gels: characterization and evaluation.

Sareen R, Kumar S, Gupta GD. Sareen R, et al. Among authors: kumar s. Curr Drug Deliv. 2011 Jul;8(4):407-15. doi: 10.2174/156720111795768013. Curr Drug Deliv. 2011. PMID: 21453256

8

Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.

Adams D, Wixner J, Polydefkis M, Berk JL, Conceição IM, Dispenzieri A, Peltier A, Ueda M, Bender S, Capocelli K, Jay PY, Yureneva E, Obici L; patisiran Global OLE study group. Adams D, et al. JAMA Neurol. 2025 Jan 13. doi: 10.1001/jamaneurol.2024.4631. Online ahead of print. JAMA Neurol. 2025. PMID: 39804640

9

Macrophages co-loaded with drug-associated and superparamagnetic nanoparticles for triggered drug release by alternating magnetic fields.

Desai O, Kumar S, Köster M, Ullah S, Sarker S, Hagemann V, Habib M, Klaassen N, Notter S, Feldmann C, Ehlert N, Hauser H, Wirth D. Desai O, et al. Among authors: kumar s. Drug Deliv Transl Res. 2025 Jan 13. doi: 10.1007/s13346-024-01774-9. Online ahead of print. Drug Deliv Transl Res. 2025. PMID: 39804440

10

Exploring the Role of [⁶⁸Ga]Ga-DOTAGA-IAC and Comparison of Its Diagnostic Performance with [¹⁸F]F-FDG PET/CT in Radioiodine Refractory Differentiated Thyroid Carcinoma.

Kumar SA, Sood A, Kumar R, Pandey S, Shukla J, Mittal BR, Satz S. Kumar SA, et al. Cancer Biother Radiopharm. 2025 Jan 13. doi: 10.1089/cbr.2024.0166. Online ahead of print. Cancer Biother Radiopharm. 2025. PMID: 39804177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,048 results

Search Page

Filters